US Stock MarketDetailed Quotes

Traws Pharma (TRAW)

Watchlist
  • 1.180
  • +0.020+1.72%
Trading Apr 27 12:08 ET
11.99MMarket Cap1.44P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Traws Pharma (TRAW) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
1,134.51%2.79M
0
0
4,694.74%2.73M
1.79%57K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
Operating revenue
1,134.51%2.79M
--0
--0
4,694.74%2.73M
1.79%57K
0.00%226K
0.00%56K
0.00%57K
0.00%57K
0.00%56K
Cost of revenue
Gross profit
Operating expense
-17.79%20.67M
38.13%7.37M
-52.81%4.06M
-32.97%3.98M
-0.15%5.26M
22.47%25.14M
18.06%5.33M
66.98%8.59M
27.30%5.94M
-14.94%5.27M
Selling and administrative expenses
-30.65%8.52M
-32.88%2.33M
-49.89%1.74M
-14.47%1.69M
-17.94%2.75M
35.13%12.29M
66.79%3.48M
29.56%3.48M
-10.58%1.98M
58.83%3.36M
-General and administrative expense
-30.65%8.52M
-32.88%2.33M
-49.89%1.74M
-14.47%1.69M
-17.94%2.75M
35.13%12.29M
66.79%3.48M
29.56%3.48M
-10.58%1.98M
58.83%3.36M
Research and development costs
-5.48%12.14M
170.99%5.04M
-54.80%2.31M
-42.20%2.29M
31.07%2.51M
12.40%12.85M
-23.66%1.86M
107.85%5.11M
61.40%3.96M
-53.14%1.91M
Operating profit
28.24%-17.88M
-39.60%-7.37M
52.50%-4.06M
78.77%-1.25M
0.17%-5.2M
-22.72%-24.91M
-18.29%-5.28M
-67.73%-8.54M
-27.64%-5.88M
15.07%-5.21M
Net non-operating interest income expense
Other net income (expense)
119.10%27.05M
99.70%-75K
52.46%93K
100.28%334K
11,556.33%26.69M
-10,589.85%-141.61M
-8,964.75%-24.64M
-82.57%61K
-32,671.94%-117.26M
-36.74%229K
Gain on sale of security
208.71%26.57M
---89K
---3K
--146K
--26.51M
---24.44M
----
----
----
----
Special income (charges)
--0
--0
--0
--0
----
---117.46M
--0
--0
---117.46M
----
-Less:Other special charges
----
----
----
----
----
--117.46M
--0
----
--117.46M
----
Other non- operating income (expenses)
65.40%478K
106.80%14K
57.38%96K
-8.29%188K
-21.40%180K
-78.59%289K
-174.10%-206K
-82.57%61K
-43.06%205K
-36.74%229K
Income before tax
105.51%9.17M
75.13%-7.44M
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
Income tax
Net income
105.51%9.17M
75.13%-7.44M
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
Net income continuous Operations
105.51%9.17M
75.13%-7.44M
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
Minority interest income
Net income attributable to the parent company
105.51%9.17M
75.13%-7.44M
53.25%-3.96M
99.26%-915K
531.27%21.49M
-778.84%-166.52M
-615.15%-29.92M
-78.84%-8.48M
-2,797.48%-123.14M
13.71%-4.98M
Preferred stock dividends
102.06%2.31M
75.95%-2.05M
86.84%-927K
99.72%-290K
-111.85M
-8.5M
-7.04M
-102.37M
Other preferred stock dividends
Net income attributable to common stockholders
112.56%6.87M
74.80%-5.4M
-111.79%-3.04M
96.99%-625K
531.27%21.49M
-188.55%-54.67M
-411.93%-21.42M
69.76%-1.43M
-388.80%-20.77M
13.71%-4.98M
Basic earnings per share
102.36%0.83
87.56%-0.73
77.18%-0.34
99.46%-0.11
136.66%2.17
-56.00%-35.21
-17.81%-5.867
73.58%-1.49
-310.40%-20.52
15.43%-5.92
Diluted earnings per share
102.33%0.82
87.56%-0.73
77.18%-0.34
99.46%-0.11
135.30%2.09
-56.00%-35.21
-17.81%-5.867
73.58%-1.49
-310.40%-20.52
15.43%-5.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 1,134.51%2.79M004,694.74%2.73M1.79%57K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K
Operating revenue 1,134.51%2.79M--0--04,694.74%2.73M1.79%57K0.00%226K0.00%56K0.00%57K0.00%57K0.00%56K
Cost of revenue
Gross profit
Operating expense -17.79%20.67M38.13%7.37M-52.81%4.06M-32.97%3.98M-0.15%5.26M22.47%25.14M18.06%5.33M66.98%8.59M27.30%5.94M-14.94%5.27M
Selling and administrative expenses -30.65%8.52M-32.88%2.33M-49.89%1.74M-14.47%1.69M-17.94%2.75M35.13%12.29M66.79%3.48M29.56%3.48M-10.58%1.98M58.83%3.36M
-General and administrative expense -30.65%8.52M-32.88%2.33M-49.89%1.74M-14.47%1.69M-17.94%2.75M35.13%12.29M66.79%3.48M29.56%3.48M-10.58%1.98M58.83%3.36M
Research and development costs -5.48%12.14M170.99%5.04M-54.80%2.31M-42.20%2.29M31.07%2.51M12.40%12.85M-23.66%1.86M107.85%5.11M61.40%3.96M-53.14%1.91M
Operating profit 28.24%-17.88M-39.60%-7.37M52.50%-4.06M78.77%-1.25M0.17%-5.2M-22.72%-24.91M-18.29%-5.28M-67.73%-8.54M-27.64%-5.88M15.07%-5.21M
Net non-operating interest income expense
Other net income (expense) 119.10%27.05M99.70%-75K52.46%93K100.28%334K11,556.33%26.69M-10,589.85%-141.61M-8,964.75%-24.64M-82.57%61K-32,671.94%-117.26M-36.74%229K
Gain on sale of security 208.71%26.57M---89K---3K--146K--26.51M---24.44M----------------
Special income (charges) --0--0--0--0-------117.46M--0--0---117.46M----
-Less:Other special charges ----------------------117.46M--0------117.46M----
Other non- operating income (expenses) 65.40%478K106.80%14K57.38%96K-8.29%188K-21.40%180K-78.59%289K-174.10%-206K-82.57%61K-43.06%205K-36.74%229K
Income before tax 105.51%9.17M75.13%-7.44M53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M
Income tax
Net income 105.51%9.17M75.13%-7.44M53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M
Net income continuous Operations 105.51%9.17M75.13%-7.44M53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M
Minority interest income
Net income attributable to the parent company 105.51%9.17M75.13%-7.44M53.25%-3.96M99.26%-915K531.27%21.49M-778.84%-166.52M-615.15%-29.92M-78.84%-8.48M-2,797.48%-123.14M13.71%-4.98M
Preferred stock dividends 102.06%2.31M75.95%-2.05M86.84%-927K99.72%-290K-111.85M-8.5M-7.04M-102.37M
Other preferred stock dividends
Net income attributable to common stockholders 112.56%6.87M74.80%-5.4M-111.79%-3.04M96.99%-625K531.27%21.49M-188.55%-54.67M-411.93%-21.42M69.76%-1.43M-388.80%-20.77M13.71%-4.98M
Basic earnings per share 102.36%0.8387.56%-0.7377.18%-0.3499.46%-0.11136.66%2.17-56.00%-35.21-17.81%-5.86773.58%-1.49-310.40%-20.5215.43%-5.92
Diluted earnings per share 102.33%0.8287.56%-0.7377.18%-0.3499.46%-0.11135.30%2.09-56.00%-35.21-17.81%-5.86773.58%-1.49-310.40%-20.5215.43%-5.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.78%
Sample Name
Sample Code
 +8.23%
Sample Name
Sample Code
 +7.85%
4
VanEck Oil Services ETF
OIH
+5.40%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.22%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.17%
Sample Name
Sample Code
 +5.73%
Sample Name
Sample Code
 +4.67%
4
ASE Technology
ASX
+4.51%
5
Qifu Technology
QFIN
+0.56%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -